| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | $1.79B+6.0% | $1.68B+1.2% | $1.67B-5.2% | $1.76B+16.3% | $1.51B+28.4% | $1.18B-0.8% | $1.19B-99.9% | $1.21T+105900.1% | $1.14B |
| Cost of sales | $1.48B+8.8% | $1.36B+3.2% | $1.32B-6.9% | $1.41B+15.2% | $1.23B+24.7% | $983.6M+6.6% | $922.7M-99.9% | $956.45B+103119.9% | $926.6M |
| Gross margin | $308.6M-5.3% | $326.0M-6.6% | $349.0M+1.5% | $343.9M+21.2% | $283.8M+47.3% | $192.6M-26.7% | $262.7M-99.9% | $251.36B+118004.7% | $212.8M |
| Selling, general, and administrative expense | $143.1M-1.7% | $145.6M-7.8% | $157.9M-6.7% | $169.3M+3.4% | $163.8M+22.3% | $134.0M-9.0% | $147.2M-99.9% | $153.49B+106282.7% | $144.3M |
| Research and development expense | $25.9M-10.6% | $29.0M+5.4% | $27.5M-5.0% | $29.0M+9.0% | $26.6M+31.0% | $20.3M+11.0% | $18.3M-99.9% | $15.19B+108526.0% | $14.0M |
| Goodwill impairment | $0-100.0% | $56.1M | $0 | $0 | — | $9.1M-21.7% | $11.6M | $0 | $0 |
| Long-lived asset impairment | $0-100.0% | $17.1M | $0 | $0 | — | — | — | — | — |
| Loss on asset disposal | $6.4M | $0 | — | $0 | — | — | — | — | — |
| Restructuring expense (Note E) | $3.2M-53.9% | $6.8M+79.1% | $3.8M+143.1% | $1.6M+459.1% | -$438K-103.9% | $11.2M+1331.5% | $785K-100.0% | $5.60B+869309.9% | $644K |
| Other — net (Note F) | $26.7M+50.8% | $17.7M-24.2% | $23.3M-3.8% | $24.2M+44.8% | $16.7M+97.8% | $8.5M-28.2% | $11.8M-99.9% | $15.33B+110272.1% | $13.9M |
| Operating profit | $109.8M+132.5% | $47.2M-65.4% | $136.4M+13.9% | $119.8M+55.3% | $77.1M+838.7% | $8.2M-88.4% | $70.5M-99.9% | $61.75B+154160.4% | $40.0M |
| Other non-operating (income) expense — net (Note P) | -$2.4M+0.2% | -$2.4M+9.9% | -$2.7M+48.4% | -$5.3M-2.6% | -$5.1M-29.9% | -$3.9M-214.8% | $3.4M-100.0% | $42.68B+2939500.6% | $1.5M |
| Interest expense — net (Note G) | $30.7M-11.7% | $34.8M+11.0% | $31.3M+43.0% | $21.9M | — | — | — | — | — |
| Total income (loss) before income taxes | $81.5M+447.2% | $14.9M-86.2% | $107.8M+4.6% | $103.1M+33.3% | $77.3M+834.4% | $8.3M-87.4% | $65.5M-99.6% | $16.60B+45503.9% | $36.4M |
| Income tax expense (Note H) | $6.7M-25.5% | $9.0M-25.7% | $12.1M-29.1% | $17.1M+252.7% | $4.9M+167.5% | -$7.2M-159.2% | $12.1M+100.3% | -$4.45B-17923.2% | $24.9M |
| Net income | $74.8M+1170.8% | $5.9M-93.8% | $95.7M+11.3% | $86.0M+18.6% | $72.5M+368.7% | $15.5M-71.0% | $53.4M-99.7% | $21.04B+183674.3% | $11.5M |
| Net income per share of common stock (in dollars per share) | $3580.00+1178.6% | $280.00-93.9% | $4580.00+10.6% | $4140.00+16.6% | $3550.00+467005.3% | $0.76-71.0% | $2.62+151.9% | $1.04+82.5% | $0.57 |
| Basic (in shares) | 20.8M+0.1% | 20.7M+0.5% | 20.6M+0.5% | 20.5M+0.4% | 20.4M+0.4% | 20.3M-0.1% | 20.4M+0.8% | 20.2M+0.9% | 20.0M |
| Diluted (in shares) | 20.9M-0.1% | 20.9M+0.1% | 20.9M+0.7% | 20.8M+0.3% | 20.7M+0.4% | 20.6M-0.3% | 20.7M+0.2% | 20.6M+1.0% | 20.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.